Skip to main navigation Skip to search Skip to main content

Cost-effectiveness of hydroxychloroquine retinopathy screening: the current guideline versus no screening and reduced regimens

  • Sara W. Quist*
  • , Sophie te Dorsthorst
  • , Roel D. Freriks
  • , Maarten J. Postma
  • , Carel B. Hoyng
  • , Freekje van Asten
    • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Cost-effectiveness of hydroxychloroquine retinopathy screening: the current guideline versus no screening and reduced regimens'. Together they form a unique fingerprint.
Sort by

Keyphrases

Nursing and Health Professions

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology